The new EFPIA Disclosure Code – Is the Need for Transparency Outweighing Data Privacy Compliance?

February 2016

Abstract

European Federation of Pharmaceutical Industries and Associations (EFPIA) adopted on 24 June 2013, the EFPIA Disclosure Code, that is a code of conduct which obliges its member companies, from 2016, onwards, to make public the details of payments and transfers of value made to healthcare professionals (HCPs) and healthcare organizations (HCOs). The first disclosures will be made in June 2016 and will concern information about Transfers of Value ( ToV) made in 2015. In order to help its Members to be prepared for that obligation, EFPIA has launched a new website: --“Pharmadisclosure.eu”—aiming to highlight the new disclosure rules, follow best practices in the implementation of the Disclosure Code and monitor compliance in the 33 countries involved in the initiative (i.e. the 28 EU member states, plus Switzerland, Russia, Ukraine, Turkey and Serbia).

Author

John Giannakakis

Regional Counsel Southern Europe , G4s Rms , Greece

John Giannakakis has a 25 year experience as Corporate Counsel and freelance litigator in different and challenging industries i.e. Insurance, Real Estate, Consumer Goods, Pharmaceuticals and Security & Investigations. John holds a BSc in Law from the University of Athens and an LLM from Ludwig Maximilian University in Munich . John is a Certified Information Privacy Professional for Europe at International Association of Privacy Professionals ( IAPP).

Company

G4s Rms

. G4S is the world’s leading international security solutions group, which specialises in secure outsourcing in countries and sectors where security and safety risks are considered a strategic threat. We make a difference by helping people to operate in safe and secure environments where they can thrive and prosper and we believe this role can only grow in importance. G4S is the largest employer on the London Stock Exchange, with operations in more than 125 countries and over 620,000 employees. In this annual report we feature the important work carried out by our employees across our 125 countries. We are proud of the role they play in securing your world. With strong market positions in developed and developing markets complementing global outsourcing trends, G4S has a sustainable growth strategy. Our strategy for enhanced growth consists of the following key components. 1.Drive outsourcing in all markets 2.Focus on sectors where security and safety are key 3.Develop long-term partnerships with large customers 4.Transfer expertise from more developed markets into key developing markets 5.Acquire businesses to accelerate organic growth potential Specialties electronic monitoring, security services, secure solutions, youth custody and treatment programs, cash solutions, manned guarding Website http://www.g4s.com Industry Security and Investigations Type Public Company Headquarters 5th Floor, Southside 105 Victoria Street London, SW1E 6QT United Kingdom

Pharmaceutical Industry is very risky business, not only that the company needs to grow its profit but it must show to the people that they contribute to the human health...Read more

Tri Junanto Wicaksono

Head of GA & Legal, PT. Amerta Indah Otsuka, Indonesia

Corporate Conglomerates: Advantages, Disadvantages, Successes and Failures, Including Case Studies of General Electric and Berkshire Hathaway

This article discusses the rise and fall of corporate structures commonly referred to as “conglomerates.” They represent a collection of different companies, either in distinct industries or concentrated in one...Read more

Bruce Ortwine

General Counsel (retired), Americas; Adviser, Global Legal and Compliance (Retired), Sumitomo Mitsui Trust Bank, Limited and Sumitomo Mitsui Trust Holdings, Inc., USA

Patent Strategies for Attenuated Pathogen Vaccines

Malaria is a major health concern for people traveling to and living in malaria-endemic areas, causing 249 million clinical cases and 608,000 deaths in 2022, numbers essentially unchanged over the...Read more

David Dolberg

Senior Director of Intellectual Property, Sanaria Inc., USA

Ways to Avoid Having your Patents Cellected*

The Court of Appeals for the Federal Circuit caused frustrations when it decided to affirm the U.S. Patent Office’s findings that claims in four patents were unpatentable because they are...Read more

Tom Irving

Partner, Marbury Law Group, USA

Xiaoguang Michelle Gao

Associate VP - Assistant General Patent Counsel , Eli Lilly and Company, USA

Michelle E. O'Brien